CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- 424B3 Offering Prospectus
- 4 Open-market sale Chief Financial Officer sold 24,880 shares at $6.96 ($173,257)
- 4 Open-market sale Chief Executive Officer sold 67,971 shares at $6.96 ($473,330)
- 4 Open-market sale SVP, Chief Legal Officer sold 12,050 shares at $6.96 ($83,913)
- 4 Open-market sale Chief Commercial Officer sold 12,606 shares at $6.96 ($87,784)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 11,000 shares at $5.92 ($65,087)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Other disposition Chief Commercial Officer disposed of 222 shares (other)
- 4 Open-market sale Director sold 18,160 shares at $5.71 ($103,695)
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 4 Open-market sale SVP, Chief Legal Officer sold 11,131 shares at an average $5.36 ($59,646)
- 4 Planned sale Chief Financial Officer sold 49,338 shares at an average $5.38 ($265,242)
Page 2 of 66 · 1,318 filings